Shoreline Biosciences, Inc., a biopharmaceutical company developing disease modifying iNK cell therapies for autoimmune ...

In this competitive retail panorama, sourcing excellent mobile accessories at affordable charges is important for business ...

H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Celcuity (CELC – Research Report) today and set a price target ...

In a report released yesterday, Gregory Renza from RBC Capital maintained a Hold rating on Inovio Pharmaceuticals (INO – Research ...